Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°©»ó¼± À¯µÎ»ó¾ÏÀ» µ¿¹ÝÇÑ ÃéÀåÀÇ Àå¾×¼º ³¶¼±Á¾ 1¿¹ A Case of Pancreatic Serous Cystadenoma Associated with Papillary Thyroid Cancer

´ëÇѾÏÇÐȸÁö 1999³â 31±Ç 1È£ p.201 ~ 207
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÁøÈ«/Jin Hong Park ÀÌâ·Ä/ÀÌÁØÈ£/ÃÖ¼ÒÁø/ÃÖ¼ºÈ£/¼Õ¼ºÇ¥/Chang Ryoul Lee/Jun Ho Lee/So Jin Choi/Sung Ho Choi/Sung Pio Son

Abstract

¼­·Ð
ÃéÀåÀÇ ³¶¼± º´º¯Áß ´ëºÎºÐÀº °¡¼º³¶Á¾À¸·Î ¾à 85% Á¤µµ¸¦ Â÷ÁöÇÏ°í ½Å»ý¹°¿¡ ÀÇÇÑ º´º¯
Àº ºñ±³Àû µå¹® ÁúȯÀ¸·Î ¾à 10%¿¡¼­ 15%¸¦ Â÷ÁöÇÑ´Ù. º´¸®ÇÐÀûÀ¸·Î °¡¼º³¶Á¾ÀÌ ¼¶À¯¼º
Á¶Á÷À¸·Î µÇ¾î Àִµ¥ ºñÇØ ½Å»ý¹° ³¶Á¾Àº »óÇǼ¼Æ÷·Î ±¸¼ºµÈ ³»º®À» °¡Áö°í ³»º®À» ±¸¼ºÇÏ
´Â »óÇǼ¼Æ÷ÀÇ Á¾·ù¿¡ µû¶ó Å©°Ô Àå¾×¼º ³¶¼±Á¾(serous cystadenoma), Á¡¾×¼º ³¶Á¾
(mucinous cystic neoplasm), ±×¸®°í À¯µÎ³¶Á¾(papillary cystic neoplasm) µîÀ¸·Î ºÐ·ùµÈ´Ù.
Á¡¾×¼º ³¶¼±Á¾ÀÎ °æ¿ì¿¡´Â ¾Ç¼ºÈ­ÀÇ °¡´É¼ºÀÌ ÀÖ°í, Àå¾×¼º ³¶¼±Á¾ÀÎ °æ¿ì¿¡´Â °ú°Å¿¡´Â ¾ç
¼ºÁ¾¾çÀ¸·Î ¾Ë·ÁÁ® ÀÖ¾úÀ¸³ª ÃÖ±Ù 4°æ¿ì¿¡¼­ ¾Ç¼ºÈ­°¡ º¸°íµÇ¾ú´Ù.
Àå¾×¼º ³¶¼±Á¾ÀÇ °æ¿ì ¼Ò³¶¼º ³¶¼±Á¾(microcystic adenoma) ȤÀº ±Û¸®ÄÚ°Õ ÇÔÀ¯ ³¶¼±Á¾
(glycogen-rich cystadenoma)À¸·Î ºÒ¸®¿öÁö´ø ÁúȯÀε¥, ÃÖ±Ù ´ë³¶¼º º´º¯(macrocystic
variants)ÀÌ ¹ß°ßµÇ¾î '¼Ò³¶¼º' À̶ó´Â Ç¥Çö¿¡ ¹®Á¦°¡ Á¦±âµÇ°í ÀÖ´Ù. Àå¾×¼º ³¶¼±Á¾Àº Áß³â
¿©¼º¿¡¼­ È£¹ßÇÏ°í ÁÖ·Î º¹ºÎÁ¾±«³ª ¸ðÈ£ÇÑ »óº¹ºÎ µ¿ÅëÀ¸·Î ³ªÅ¸³ª¸ç, µ¿¹ÝÁúȯÀ¸·Î´Â ´ã
¼®Áõ, ´ç´¢º´, °íÇ÷¾Ð, ½ÊÀÌÁöÀå ±Ë¾ç, ºÒÀÓ, ºñ¸¸, °©»ó¼± ±â´ÉÀÌ»ó µîÀÌ º¸°íµÇ¾ú°í, ÀúÀÚµé
ÀÇ °æ¿ì¿Í °°ÀÌ °©»ó¼± À¯µÎ»ó¾ÏÀ» µ¿¹ÝÇÑ °æ¿ì´Â Àü ¼¼°èÀûÀ¸·Î ´ÜÁö 2¿¹¸¸ÀÌ º¸°íµÇ¾ú°í,
±¹³»¿¡¼­´Â º¸°íµÈ ÀûÀÌ ¾ø´Ù. µ¿¹ÝÁúȯÀÇ º´¿ø·ÐÀº Àß ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀ¸³ª ³ªÀÌ°¡ µé¾î°¨
¿¡ µû¶ó ¹ß»ýÇϰųª ȤÀº ¿ì¿¬È÷ ¼ö¹ÝµÈ °ÍÀ¸·Î º¸ÀδÙ.
ÀúÀÚµéÀº ÃÖ±Ù 61¼¼ ¿©ÀÚ¿¡¼­ °©»ó¼± À¯µÎ»ó¾ÏÀ» µ¿¹ÝÇÑ ÃéÀåÀÇ Àå¾×¼º ³¶¼±Á¾ 1¿¹¸¦ °æ
ÇèÇÏ¿´±â¿¡ Áõ·Ê º¸°íÇÏ´Â ¹ÙÀÌ´Ù.
#ÃÊ·Ï#
The most common pancreatic cystic lesion is pancreatic pseudocyst which represents
about 85%. Primary cystic neoplasms represent about 10 to 15% of the lesion.
Pathologically cystic neoplasms can be classified into serous cystadenoma, mucinous
cystadenoma and papillary cystic neoplasm by epithelial lining-cell, whereas pseudocyst
is characterized by fibrotic capsules. Mucinous form is known to be premalignant or
malignant and serous cystadenoma was known to be benign in the past, but recently 4
cases of malignant transformation have been reported.
Serous cystadenoma is described under a variety of names, including microcystic
adenoma and glycogen-rich cystadenoma but recently macrocystic variants have been
reported. Serous cystadenoma is most commonly seen in middle aged women with
symptoms of vague upper abdominal pain or palpable mass. It is sometimes associated
with extrapancreatic diseases such as gallstones, diabetes mellitus, hypertension,
duodenal ulcers, sterility, obesity and thymic dysfunction, but coexisting papillary thyroid
cancer have been reported in only 2 cases to our knowledge. The pathogenesis of
associated diseases is unknown and appears to be due to function of age of the patients
or incidental occurrence. Herein, we report a patient who had a pancreatic serous
cystadenoma coexisting with papillary thyroid cancer. Since pancreatic serous
cystadenoma can occur in association with papillary thyroid cancer, examination of
thyroid seems to be advisable when pancreatic serous cystadenoma is found.

Å°¿öµå

Pancreatic serous cystadenoma; Papillary thyroid cancer;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS